|
Siemens Medical Solutions
|
|
|
|
The use of cardiac markers, specifically cardiac troponin I, has become the standard for the detection of myocardial cell damage1-3 and for risk stratification of chest pain patients.2,4 The excellent cardiac sensitivity and “nearly absolute” cardiac specificity of the second-generation cTnI assay helps detect microscopic myocardial necrosis that is associated with a high risk.1-3
|